These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30004992)

  • 1. Risk stratification in pulmonary arterial hypertension.
    Weatherald J; Boucly A; Sitbon O
    Curr Opin Pulm Med; 2018 Sep; 24(5):407-415. PubMed ID: 30004992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment in pulmonary arterial hypertension.
    Raina A; Humbert M
    Eur Respir Rev; 2016 Dec; 25(142):390-398. PubMed ID: 27903661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
    Anderson JJ; Lau EM; Lavender M; Benza R; Celermajer DS; Collins N; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keating D; Kermeen F; Kotlyar E; McWilliams T; Rhodes B; Steele P; Thakkar V; Williams T; Whitford H; Whyte K; Weintraub R; Wrobel JP; Keogh A; Strange G
    Chest; 2020 Jan; 157(1):162-172. PubMed ID: 31563497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
    Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
    J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction Models and Scores in Pulmonary Hypertension: A Review.
    Mouratoglou SA; Bayoumy AA; Noordegraaf AV
    Curr Pharm Des; 2021; 27(10):1266-1276. PubMed ID: 33155897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
    Delcroix M; Staehler G; Gall H; Grünig E; Held M; Halank M; Klose H; Vonk-Noordegraaf A; Rosenkranz S; Pepke-Zaba J; Opitz CF; Gibbs JSR; Lange TJ; Tsangaris I; Huscher D; Pittrow D; Olsson KM; Hoeper MM
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
    Benza RL; Miller DP; Foreman AJ; Frost AE; Badesch DB; Benton WW; McGoon MD
    J Heart Lung Transplant; 2015 Mar; 34(3):356-61. PubMed ID: 25447572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
    Yogeswaran A; Gall H; Fünderich M; Wilkins MR; Howard L; Kiely DG; Lawrie A; Hassoun PM; Sirenklo Y; Torbas O; Sweatt AJ; Zamanian RT; Williams PG; Frauendorf M; Arvanitaki A; Giannakoulas G; Saleh K; Sabbour H; Cajigas HR; Frantz R; Al Ghouleh I; Chan SY; Brittain E; Annis JS; Pepe A; Ghio S; Orfanos S; Anthi A; Majeed RW; Wilhelm J; Ghofrani HA; Richter MJ; Grimminger F; Sahay S; Tello K; Seeger W;
    Chest; 2024 Sep; 166(3):585-603. PubMed ID: 38508334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
    Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
    Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dart to the target: an alternative bull's eye parametric display for European Society of Cardiology / European Respiratory Society goal-orientated risk reduction strategy in pulmonary arterial hypertension.
    Kaymaz C; Akbal OY; Hakgor A; Tokgoz HC; Tanyeri S
    Pulm Circ; 2018; 8(3):2045894018780522. PubMed ID: 29767575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.
    Leuchte HH; Ten Freyhaus H; Gall H; Halank M; Hoeper MM; Kaemmerer H; Kähler C; Riemekasten G; Ulrich S; Schwaiblmair M; Ewert R
    Int J Cardiol; 2018 Dec; 272S():20-29. PubMed ID: 30266353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment in severe pulmonary hypertension due to interstitial lung disease.
    Yogeswaran A; Tello K; Faber M; Sommer N; Kuhnert S; Seeger W; Grimminger F; Ghofrani HA; Richter MJ; Gall H
    J Heart Lung Transplant; 2020 Oct; 39(10):1118-1125. PubMed ID: 32690230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Kylhammar D; Kjellström B; Hjalmarsson C; Jansson K; Nisell M; Söderberg S; Wikström G; Rådegran G
    Eur Heart J; 2018 Dec; 39(47):4175-4181. PubMed ID: 28575277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools.
    Dardi F; Guarino D; Ballerini A; Bertozzi R; Donato F; Cennerazzo F; Salvi M; Nardi E; Magnani I; Manes A; Galiè N; Palazzini M
    ERJ Open Res; 2024 Jul; 10(4):. PubMed ID: 39104950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk stratification methods and their significance in pulmonary arterial hypertension].
    Avdeev SN; Tsareva NA
    Ter Arkh; 2019 Sep; 91(9):150-157. PubMed ID: 32598827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.